home / stock / livn / livn news


LIVN News and Press, LivaNova PLC From 02/28/22

Stock Information

Company Name: LivaNova PLC
Stock Symbol: LIVN
Market: NASDAQ
Website: livanova.com

Menu

LIVN LIVN Quote LIVN Short LIVN News LIVN Articles LIVN Message Board
Get LIVN Alerts

News, Short Squeeze, Breakout and More Instantly...

LIVN - Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2021 Update

David Einhorn's 13F stock portfolio value increased from $1.49B to $1.75B this quarter. Greenlight increased Capri Holdings, ODP Group, Livanova, & Victoria’s Secret while reducing Twitter, Concentrix, & EchoStar. They also added Global Payments while dropping AerCap an...

LIVN - LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea

Study to evaluate effectiveness of hypoglossal nerve stimulation LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study, “Treatin...

LIVN - LivaNova PLC (LIVN) CEO Damien McDonald on Q4 2021 Results - Earnings Call Transcript

LivaNova PLC (LIVN) Q4 2021 Earnings Conference Call February 23, 2022, 8:00 AM ET Company Participants Damien McDonald – Chief Executive Officer Matthew Dodds – Senior Vice President of Corporate Development Alex Shvartsburg – Chief Financial Officer Conference Call Part...

LIVN - LivaNova PLC 2021 Q4 - Results - Earnings Call Presentation

The following slide deck was published by LivaNova PLC in conjunction with their 2021 Q4 earnings call. For further details see: LivaNova PLC 2021 Q4 - Results - Earnings Call Presentation

LIVN - LivaNova PLC Non-GAAP EPS of $0.57 beats by $0.05, revenue of $270.1M beats by $2.9M

LivaNova PLC press release (NASDAQ:LIVN): Q4 Non-GAAP EPS of $0.57 beats by $0.05. Revenue of $270.1M (+0.2% Y/Y) beats by $2.9M. 2022 Guidance: The company expects worldwide net sales for full-year 2022 to grow between 3 and 5 percent on a constant-currency basis vs consensus of$1....

LIVN - LivaNova Reports Fourth-Quarter and Full-Year 2021 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2021. For the fourth quarter of 2021, worldwide sales from continuing operations were $270.1 million, an increase of 0.2 p...

LIVN - LivaNova Continues To Be A Spring-Loaded Opportunity In Neuromodulation

As per our first article, DTD remains incredibly attractive, even with conservative prevalence figures. The whole neuromodulation opportunity renders the company a potential growth engine. Three major trials are underway for three unmet medical needs which will rocket profile to o...

LIVN - LivaNova to Announce Fourth-Quarter and Full-Year 2021 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2021 results on Wednesday, February 23, 2022 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-...

LIVN - Tracking William Nygren's Harris Associates Portfolio - Q3 2021 Update

Harris Associates’ 13F portfolio value decreased from $62.80B to $62.77B this quarter. They increased Fiserv, Humana, and Alibaba while decreasing CNH Industrial, Liberty Global, and Automatic Data Processing. The top three positions are Alphabet, Bank of America, and Chart...

LIVN - LivaNova (LIVN) Investor Day 2021 Presentation - Slideshow

The following slide deck was published by LivaNova PLC in conjunction with this event. For further details see: LivaNova (LIVN) Investor Day 2021 Presentation - Slideshow

Previous 10 Next 10